1. Home
  2. DTCX vs INMB Comparison

DTCX vs INMB Comparison

Compare DTCX & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datacentrex Inc. Common Stock

DTCX

Datacentrex Inc. Common Stock

N/A

Current Price

$2.02

Market Cap

80.7M

Sector

Technology

ML Signal

N/A

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

HOLD

Current Price

$2.46

Market Cap

64.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTCX
INMB
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.7M
64.7M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
DTCX
INMB
Price
$2.02
$2.46
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$5.40
AVG Volume (30 Days)
288.0K
317.9K
Earning Date
04-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
8.00
11.85
EPS
N/A
N/A
Revenue
$2,446.00
$50,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
257.14
52 Week Low
$1.51
$1.09
52 Week High
$3.80
$2.60

Technical Indicators

Market Signals
Indicator
DTCX
INMB
Relative Strength Index (RSI) 46.35 66.18
Support Level $1.74 $1.16
Resistance Level $2.31 $2.50
Average True Range (ATR) 0.29 0.13
MACD -0.06 0.00
Stochastic Oscillator 14.07 76.92

Price Performance

Historical Comparison
DTCX
INMB

About DTCX Datacentrex Inc. Common Stock

Datacentrex Inc is a digital infrastructure and capital deployment company that owns and operates Scrypt compute assets and evaluates strategic transactions across asset-backed operating businesses. Its current operating platform is centered on owned and operated Scrypt-based proof-of-work compute deployed through third-party colocation facilities. Datacentrex monetizes this compute through hashrate marketplace mechanisms and manages a treasury of digital assets and cash in a manner intended to preserve capital and support opportunistic, accretive deployment. The company's operations are principally operated remotely at various data centers throughout the United States.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Share on Social Networks: